Académique Documents
Professionnel Documents
Culture Documents
Hyperplasia
Ririe F Malisie
Subbagian Endokrinologi Pediatri
Bagian Ilmu Kesehatan Anak
RSUD Arifin Achmad / FKUR
Pekanbaru - Riau
Objectives
Describe the problems of CAH
Describe the current situation in Indonesia
Conclusion
Epidemiology
Incidence 1:15000 (global)
Autosomal recessive
most common cause of
ambiguous genitalia
female pseudohermaphroditism (FPH)
Clinical manifestation
Heterosexual
Precocity
46, XX
Early signs of
puberty
Virilism
CAH
ADRENAL AXIS
Adrenal steroid
enzymes
E n z y me
P450scc
Location
Mitochondria
Chromosome
15q23-24 (CYPscc)
P450c17
3HSD
P450c21
P450c11
P450c18
Mitochondria
8q21-22 (CYP11B1)
8q21-22 (CYP11B2)
11-DOC
corticosterone
11-deoxycortisol
CORTISOL
18-hydroxycortikosterone
ALDOSTERON
DHEA
Androstenedione
TESTOSTERONE
CYP21 deficiency
cholesterol
Corticoste
rone
18-hydroxycortikosterone
ALDOSTERON
DHEA
Androstenedione
11-deoxycortisol
11-DOC
CORTISOL
TESTOSTERONE
Hypothalamus
Adrenal
axis in CAH
CRH
(-)
(-)
ACTH
CORTISOL
Mechanism of disease
enzyme defect of the adrenal cortex disruption
in steroid biosynthesis cortisol deficiency
Addison crisis prone
compensatory increase of androgen secretion
virilisation
mineralocorticoid arm affected decrease
aldosterone electrolyte imbalance (sodium loss)
decrease androgen secretion undervirilised male
increased deoxycorticosterone production
hypertension
Enzyme
defect
P450scc
Clinical
Manifestations
MPH
FPH
-
Salt
losing
+
Hyper
tension
-
CYP21
CYP11
3HSD
CYP17
failure to thrive
ambiguous genitalia in females but not in males.
Classification -Simple
Virilizing
Enzyme activity 1-2%
Clinical
male : isosexual
Classification-Non classical
Enzyme activity 20-50%
rarely diagnosed before puberty
hirsutism: CYP21 9%; 3HSD 17%; CYP11
6.5%
premature adrenarche/pubarche: CYP21
6.6%; 3HSD: 10%
Intersex male: 46,XY female
hypertension in children and young adults
Location
Frequency
(%)
Deletion
Pro30Leu
A(C)656G
8bp
Ile172Asn
Exon6 cluster
Val281Leu
1757+T
Gln318Stop
Arg356Trp
CYP21
Exon 1
Intron 2
Exon 3
Exon 4
Exon 6
Exon 7
Exon 7
Exon 8
Exon 8
25-30
5-10
20-25
5-10
5-10
5-10
5-10
<5
5-10
10
Exon 1
4 5 6
Premature
splicing
end
Premature
splicing
end+
intron2:
11
AA
aberrant
intron2: 11 AA aberrant +
stop
stop
Substitution
SubstitutionAA
AA
Pro30
Pro30
Leu
Leu
3AA
3AAsubstitution
substitution
Ile236
Ile236
Asn
Asn
Val
237
Lys
Met 239 Lys
Substitution
SubstitutionAA
AA
Ile172
Ile172
Asn
Asn
SV
SV
Substitution
SubstitutionAA
AA
Arg
Arg356
356
Trp
Trp
Insertion
Insertion11bp:
bp:55AA
AA
aberrant
+
stop
aberrant + stop
10
Nonsense
Nonsensemutation
mutation
Gln
Gln318
318
stop
stop
Substitution
SubstitutionAA
AA
Val281
Val281
Leu
Leu
SW
SW
NC
NC
Diagnosis - clinically
ambiguous genitalia
intersex case
PCOS
Diagnosis - laboratorium
Hormonal
hyponatremia, hyperkalemia
hypoglycemia
metabolic acidosis
Hyperandrogen
Hyperandrogen
Consequences
of
Growth
Growth
ambiguousity
ambiguousity
gender
genderrole
role
precocious
precociouspuberty
puberty
Cushing
Cushing
CAH
Fertility
Fertility
Sexual
and
social
Sexual
and
social
function
function
Bone
Bone
mineralization
mineralization
virilisation
virilisation
conception
conception
birth
birth
Salt
Saltwasting
wasting
adult
adult
Addisons
Addisonscrisis
crisis
Cortisol
Cortisol (and
(andaldosterone)
aldosterone)deficiency
deficiency
death
death
Management - objectives
Prenatal
avoid surgery
Postnatal
psychology
genetic counseling
Management - Prenatal
(1)
5 weeks
8 weeks
9 weeks
or
10 - 11 weeks
CVS
continued
9 weeks
Management - Prenatal
(2)
10-11 weeks
15 weeks
amnio
16-18weeks
OGTT
Management - replacement
Prenatal dexamethasone (0,5 2 mg/day)
Surgery
Clitoroplasty
Vaginal reconstruction
before marriage
Problems of CAH
Diagnosis
intra uterine
extra uterine
Management
medicine
surgery
psychology
Problems of CAH
Prognosis
Social emergency
birth: gender
Gender role
Adult self esteem
PRENATAL TREATMENT
Success 75%
Failure
Inadequate dosage
Interruption of treatment
Delay in initiating treatment
Variability in maternal metabolic clearance
Variability of placental metabolism of the
administered glucocorticoid
PRENATAL TREATMENT
Adverse reaction
Adult height
CAH
Metanalysis (N=561)
Failure of adrenal
suppression
Hyperresponsivity of adrenal to ACTH
Abnormal steroids
Resistance to glucoscorticoid and mineralocorticoid
Alternative treatment
Adrenalectomy (Gunther et al, 1997)
Alternative regiment 1 (Merke et al,2000)
androgen blocking agent (flutamide)
Aromatase inhibitor
enzyme responsible for estrogen formation from
androgens (testolactone)
low dose hydrocortisone
vaginal stenosis
Gender role
Preference for playing with boys 82%
Masculine sport in adolescence 70%
Masculine gender role continues into adolescence and
(Slijper et al, 1992)
aulthood
Sexual functioning
Low sexual activity (10%)
Sexual orientation heterosexual
Masturbation 70%
Premawardhana et al (1997)
Problems in Indonesia
-diagnosis
Dept of Child Health Jakarta (hospital data) - 1993
Problems in Indonesia
-diagnosis
Dept of Child Health Jakarta (hospital data) - 1993
Underdiagnosed / misdiagnosed
Problems in Indonesia
-therapy
Hydrocortisone
cost
availability
Alternative
Unsatisfactory result
Team work
Geneticist, biochemist, psychology, obstetrician,
internist, radiologist, surgeon, molecular biologist and
pediatric endocrinologist
Conclusion
Medical and social emergency
Growth and development of child
Adult: short final height, fertility, and social
consequences
Current management still needs improvement
Team work is essential
Alternative management research